C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations

Journal of Pulmonary & Respiratory Medicine
doi 10.4172/2161-105x.1000375
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations

Pediatrics
Child HealthPediatricsPerinatology
2017English

C-Reactive Protein in Juvenile Chronic Arthritis: An Indicator of Disease Activity and Possibly Amyloidosis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1982English

The Role of the High-Sensitivity C-Reactive Protein in Patients With Stable Non-Cystic Fibrosis Bronchiectasis

Pulmonary Medicine
MedicinePulmonaryRespiratory Medicine
2013English

Inhaled Hypertonic Saline Reduces Pulmonary Exacerbations in Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2006English

Glucose Tolerance During Pulmonary Exacerbations in Children With Cystic Fibrosis

PLoS ONE
Multidisciplinary
2012English

Doxycycline Improves Clinical Outcomes During Cystic Fibrosis Exacerbations

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Treatment of Pulmonary Exacerbations of Cystic Fibrosis Leads to Improved Antioxidant Status

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

Effects of Puberty on Cystic Fibrosis Related Pulmonary Exacerbations in Women Versus Men

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2013English

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy